𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis

✍ Scribed by Stanley B. Cohen; Tien-Tsai Cheng; Vishala Chindalore; Nemanja Damjanov; Ruben Burgos-Vargas; Patricia DeLora; Kathleen Zimany; Helen Travers; John P. Caulfield

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
107 KB
Volume
60
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Efficacy of methotrexate treatment in pa
Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: A double-blind, randomized, placebo-controlled trial
✍ Henrike van Dongen; Jill van Aken; Leroy R. Lard; Karen Visser; H. Karel Ronday; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 124 KB πŸ‘ 2 views

## Abstract ## Objective To determine whether patients with undifferentiated arthritis (UA; inflammatory, nontraumatic arthritis that cannot be diagnosed using current classification criteria) benefit from treatment with methotrexate (MTX). ## Methods The PRObable rheumatoid arthritis: Methotrex

The efficacy and safety of leflunomide i
The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: A five-year followup study
✍ J. R. Kalden; M. Schattenkirchner; H. SΓΆrensen; P. Emery; C. Deighton; B. Rozman πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 123 KB πŸ‘ 2 views

## Abstract ## Objective To investigate the efficacy and safety of leflunomide beyond 2 years in a multinational, open‐label extension of 2 phase III double‐blind studies. ## Methods Patients with rheumatoid arthritis (RA) who received leflunomide (100 mg/day for 3 days, 10 mg/day or 20 mg/day t